Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chirality at Nitrogen, Phosphorus, and Sulfur02:30

Chirality at Nitrogen, Phosphorus, and Sulfur

6.7K
Chirality is most prevalent in carbon-based tetrahedral compounds, but this important facet of molecular symmetry extends to sp3-hybridized nitrogen, phosphorus and sulfur centers, including trivalent molecules with lone pairs. Here, the lone pair behaves as a functional group in addition to the other three substituents to form an analogous tetrahedral center that can be chiral.
A consequence of chirality is the need for enantiomeric resolution. While this is theoretically possible for all...
6.7K
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation02:17

Reduction of Alkenes: Asymmetric Catalytic Hydrogenation

3.8K
Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
3.8K
Prochirality02:05

Prochirality

4.7K
The concept of prochirality leads to the nomenclature of the individual faces of a molecule and plays a crucial role in the enantioselective reaction. It is a concept where two or more achiral molecules react to produce chiral products. A typical process is the reaction of an achiral ketone to generate a chiral alcohol. Here, the achiral reactant reacts with an achiral reducing agent, sodium borohydride, to generate an equimolar mixture of the chiral enantiomers of the product. For example, an...
4.7K
Regioselectivity and Stereochemistry of Hydroboration02:36

Regioselectivity and Stereochemistry of Hydroboration

9.2K
A significant aspect of hydroboration–oxidation is the regio- and stereochemical outcome of the reaction.
Hydroboration proceeds in a concerted fashion with the attack of borane on the π bond, giving a cyclic four-centered transition state. The –BH2 group is bonded to the less substituted carbon and –H to the more substituted carbon. The concerted nature requires the simultaneous addition of –H and –BH2 across the same face of the alkene giving syn stereochemistry.
9.2K
Regioselectivity and Stereochemistry of Acid-Catalyzed Hydration02:34

Regioselectivity and Stereochemistry of Acid-Catalyzed Hydration

9.4K
The rate of acid-catalyzed hydration of alkenes depends on the alkene's structure, as the presence of alkyl substituents at the double bond can significantly influence the rate.
9.4K
Radical Anti-Markovnikov Addition to Alkenes: Overview01:25

Radical Anti-Markovnikov Addition to Alkenes: Overview

3.9K
The addition of hydrogen bromide to alkenes in the presence of hydroperoxides or peroxides proceeds via an anti-Markovnikov pathway and yields alkyl bromides.
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dissociable peripheral and central mechanisms of monoacylglycerol lipase inhibition on pain- and depression-related behaviors in a rat model of neuropathic pain.

Pain·2026
Same author

Corrigendum to "Combination of Cornus officinalis Siebold and Moutan officinalis (L.) Lindl. alleviates the metabolic disorders of MAFLD through regulating IRE1α/ASK1/JNK pathway mediated endoplasmic reticulum stress" [J. Ethnopharmacol. 369 (2026) 121890].

Journal of ethnopharmacology·2026
Same author

Comparative analysis of natural versus ovarian stimulation cycles in intrauterine insemination by diverse infertility indications.

Annals of medicine·2026
Same author

Lactate metabolism and lactylation in female reproductive diseases: From metabolic rewiring to biomarkers and translational therapeutics.

Clinical and translational medicine·2026
Same author

International Expert Consensus Statement on Chronic Endometritis: A Comprehensive Literature Review and Modified e-Delphi Study.

Reproductive medicine and biology·2026
Same author

Association between serum chemerin and breast cancer mediated by lipid metabolism.

Discover oncology·2026

Related Experiment Video

Updated: Dec 24, 2025

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes
10:51

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

Published on: April 10, 2015

12.6K

Recognizing and stabilizing miR-21 by chiral ruthenium(II) complexes.

Yin Feng1, Jing Shu2,3, Liangzhong Yao1

  • 11The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510062 China.

BMC Chemistry
|April 9, 2020
PubMed
Summary

Chiral ruthenium(II) complexes show potential as cancer inhibitors by targeting microRNA-21 (miR-21). These complexes bind to miR-21, downregulating its expression and impacting tumor cell behavior.

Keywords:
Chiral ruthenium(II) complexesFRETMiR-21RNA binding property

More Related Videos

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor
07:12

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor

Published on: October 26, 2017

8.1K
Heterogeneous Removal of Water-Soluble Ruthenium Olefin Metathesis Catalyst from Aqueous Media Via Host-Guest Interaction
10:39

Heterogeneous Removal of Water-Soluble Ruthenium Olefin Metathesis Catalyst from Aqueous Media Via Host-Guest Interaction

Published on: August 23, 2018

8.2K

Related Experiment Videos

Last Updated: Dec 24, 2025

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes
10:51

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

Published on: April 10, 2015

12.6K
Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor
07:12

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor

Published on: October 26, 2017

8.1K
Heterogeneous Removal of Water-Soluble Ruthenium Olefin Metathesis Catalyst from Aqueous Media Via Host-Guest Interaction
10:39

Heterogeneous Removal of Water-Soluble Ruthenium Olefin Metathesis Catalyst from Aqueous Media Via Host-Guest Interaction

Published on: August 23, 2018

8.2K

Area of Science:

  • Coordination Chemistry
  • Molecular Biology
  • Cancer Research

Background:

  • MicroRNA-21 (miR-21) is a key regulator in tumor proliferation, invasion, and metastasis.
  • Targeting miR-21 offers a potential therapeutic strategy for cancer treatment.

Purpose of the Study:

  • To synthesize and characterize chiral ruthenium(II) complexes as potential miR-21 inhibitors.
  • To investigate the binding affinity, cellular uptake, and regulatory effects of these complexes on miR-21 expression.

Main Methods:

  • Synthesis of chiral ruthenium(II)-alkyne complexes (Λ-1 and Δ-1) using microwave-assisted Songogashira coupling.
  • Assessment of isomer binding capacity to miR-21.
  • Evaluation of cellular uptake and nuclear localization in MDA-MB-231 cells.
  • Analysis of miR-21 expression levels following complex treatment.

Main Results:

  • Chiral ruthenium(II) complexes Λ-1 and Δ-1 were successfully synthesized.
  • Both isomers recognized and stabilized miR-21, with the Λ-isomer exhibiting stronger binding.
  • The complexes were uptaken by MDA-MB-231 cells and localized in the nucleus.
  • Treatment with Λ-/Δ-isomer downregulated miR-21 expression.

Conclusions:

  • Chiral ruthenium(II) complexes demonstrate potential as anticancer agents.
  • These complexes function by recognizing, stabilizing, and downregulating miR-21 expression.
  • Further development of these complexes could lead to novel miR-21-targeted cancer therapies.